<DOC>
	<DOCNO>NCT00819169</DOCNO>
	<brief_summary>This multi-center , 2-part phase 1b/2 study AMG 655 combination AMG 479 conduct United States Spain . Part 1 dose escalation segment identify dose AMG 655 combination AMG 479 safe tolerable . Part 2 evaluate safety estimate efficacy AMG 655 dose select Part 1 combination AMG 479 treatment patient advance NSCLC ( non-squamous histology ; squamous histology ) , CRC , pancreatic cancer , ovarian cancer , sarcoma .</brief_summary>
	<brief_title>QUILT-3.026 : AMG 655 Combination With AMG 479 Advanced , Refractory Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Part 1 : Histologically cytologically confirm , locally advanced metastatic , treatmentrefractory solid tumor Part 2 : Histologically cytologically confirm , locally advanced metastatic : NSCLC ( squamous nonsquamous cell carcinoma ; 2 prior treatment regimen ) , Colorectal Cancer ( 2 prior treatment regimen ) , Pancreatic Cancer ( 1 prior treatment regimen ) , Ovarian cancer ( 2 prior treatment regimen ) , Sarcoma ( 2 prior treatment regimen ) , accord cohort availability Eastern Cooperative Group ( ECOG performance status 0 1 Women men ≥16 year age Adequate hematology , renal , hepatic , coagulation glycemic function . Presence uncontrolled central nervous system ( CNS ) disease Systemic chemotherapy , hormonal therapy , immunotherapy , experimental approve anticancer proteins/antibodies therapy ≤28 day enrollment . Prior treatment death receptor agonist ( include limit rhApo2L/TRAIL [ AMG951 ] , apomab , mapatumumab , lexatumumab , CS1008 ) Prior treatment IGF receptor antagonist ( include limit CP751 , 871 , MK0646 , AVE1642 IMCA12 )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>AMG 655</keyword>
	<keyword>AMG 479</keyword>
	<keyword>Apoptosis</keyword>
	<keyword>Monoclonal Antibody</keyword>
	<keyword>Tumor Necrosis Factor</keyword>
	<keyword>Insulin-like Growth Factor</keyword>
</DOC>